Male-to-female sex ratios of abnormalities detected by fluorescence in situ hybridization in a population of chronic lymphocytic leukemia patients

Hematology Reports

Volumn 5, Issue 1, 2013, Pages 13-17

  Cantú, Eduardo S ^a   McGill, John R ^b   Stephenson, Christine F ^c   Hoffmann, Heidi M ^d   Tang, Lihua ^a   Yan, Jim ^a   Glassman, Armand B ^e  

^a LABORATORY CORPORATION OF AMERICA   (United States)

^b Miraca LifeSciences   (United States)

^c HEMATOLOGICS INC   (United States)

^d Integrated Genetics   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

CLL; FISH; Sex ratios

Indexed keywords

ATM PROTEIN;

ADULT; AGED; ARTICLE; ATM GENE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOSS; GENETIC DISORDER; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEX RATIO; TRISOMY 12; UNITED STATES;

EID: 84874765341     PISSN: 20388322     EISSN: 20388330     Source Type: Journal    
DOI: 10.4081/hr.2013.e4     Document Type: Article

References (25)

1. Muller-Hermelink HK, Montserrat E, Catovsky D, et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva, Switzerland: World Health Organization; 2008. pp 180-182.
2. Kirsch-Volders M, Bonassi S, Herceg Z, et al. Commentary: gender-related differences in response to mutagens and carcinogens. Mutagenesis 2010;25:213-21.
3. Nascimento MC, Yamamoto M, Rodrigues MM, et al. CLL: chromosomal abnormalities (FISH) and their relation with clinical stage, CD38 and ZAP-70. Rev Bras Hematol Hemoter 2006;28:5-10.
4. Goldin LR, Pfeiffer RM, LI X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood 2004;104:1850-4.
5. Cartwright RA, Gurney KA, Moorman AV. Sex ratios and the risks of haematological malignancies. Br J Haematol 2002;118: 1071-7.
6. Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-6.
7. Hjalmar V, Kimby E, Matutes E, et al. Trisomy 12 and lymphoplasmacytoid lymphocytes in chronic leukemia B-cell disorder. Haematologica 1998;83:602-9.
8. nd ed. New York: A John Wiley & Sons, Inc.; 1995. pp 377-379.
9. Cordone I, Masi S, Mauro FR, et al. P53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood 1998;91:4342-9.
10. rd ed. Philadelphia: Elsevier, Churchill, Livingstone; 2004. pp 2921-2939.
11. Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 2009;18:1174-82.
12. Horner MJ, Ries LAG, Krapcho M, et al. editors. SEER Cancer Statistics Review. National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975_2006/.
13. Tabernero MD, Espinosa AB, Maillo A, et al. Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome-linked geneexpression profiles in meningiomas. The Oncologist 2007;12:1225-36.
14. Mauritzson N, Johansson B, Albin M, et al. A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur J Haematol 1999;62:95-102.
15. Ataxia-telangiectasia mutated gene: ATM. Online Mendelian inheritance in man. Baltimore: Johns Hopkins University Press; 2010.
16. Vorechovsky I, Luo L, Dyer MJS, et al. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic Tcell leukaemia. Nature Genet 1997;17:96-9.
17. Schaffner C, Idler I, Stilgenbauer S, et al. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Nat Acad Sci USA 2000;97:2773-8.
18. Schaffner C, Stilgenbauer S, Rappold GA, et al. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 1999;94:748-53.
19. Kaminsky Z, Wang SC, Petronis A. Complex disease, gender and epigenetics. Ann Med 2006;38:530-544.
20. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001;291:1284-9.
21. Lindahl T, Wood RD. Review: quality control by DNA repair. Science 1999;286:1897-905.
22. Nielander I, Martin-Subero JI, Wagner F, et al. Recurrent loss of the Y chromosome and homozygous deletions within the pseudoautosomal region 1: association with male predominance in mantle cell lymphoma. Haematologica 2008;94:949-50.
23. Horwitz MS, Mealiffe ME. Further evidence for a pseudoautosomal gene for Hodgkin's lymphoma: reply to The familial risk of Hodgkin's lymphoma ranks among the highest in the Swedish Family-Cancer Database by Altieri A and Hemminki K. Leukemia 2007;21:351.
24. Trentin L, Cabrelle A, Facco M, et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004;104:502-8.
25. Kremer E, Baker E, D'Andrea RJ, et al. A cytokine receptor gene cluster in the X-Y pseudoautosomal region? 1993;82:22-8.